BS
BSX
Market ClosedBoston Scientific Corporation
US
53.00K employees
CEO: Michael F. Mahoney
Founded: 1992
$45.29
+$0.00(+NaN%)
Market Cap
67.32B
Beta
0.56
52W Range
N/A
Dividend Yield
0.00%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
Boston Scientific’s AI short-term forecast is projecting downside risk with strong negative momentum. Analyst consensus over 12 months shows strong coverage but wide disagreement, indicating varied long-term outlooks. This divergence and short-term weakness suggest elevated investment uncertainty.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for BSX
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore BSX
BSX in the Healthcare
Large Cap